Increased Risk of Cancers, Lung Diseases, Kidney and Liver Failures, Other Medical Conditions
In a rush? You can use our Quick Contact Form to tell us the basic information about your case.
On June 30, 2021, the FDA issued a Safety Communication document concerning the June 2021 recall of certain Philips CPAP machines, BiPAP devices, and mechanical ventilators. Therein the FDA pointed out the Philips recall health risks for patients and provided a list of recalled Philips products.
That June 2021 FDA document, “Certain Philips Respironics Ventilators, BiPAP, and CPAP Machines Recalled Due to Potential Health Risks: FDA Safety Communication“, started with this rather alarming paragraph:
The U.S. Food and Drug Administration (FDA) is alerting people who use Philips Respironics ventilators, BiPAP, and CPAP machines and their health care providers that Philips Respironics has recalled certain devices (see table below) due to potential health risks. The polyester-based polyurethane (PE-PUR) sound abatement foam, which is used to reduce sound and vibration in these affected devices, may break down and potentially enter the device’s air pathway. If this occurs, black debris from the foam or certain chemicals released into the device’s air pathway may be inhaled or swallowed by the person using the device.
Thereafter, the FDA addressed the Philips recall health risks for patients and presented a table with Philips “product identification” information about the June 2021 recall of certain Philips CPAP machines, BiPAP devices, and mechanical ventilators, i.e., a list of recalled Philips products.
Warnings about risks of “toxic or carcinogenic effects to organs, such as kidneys and liver”
In their June 2021 Safety Communication about the recalled Philips breathing products, the FDA pointed out some of the Philips recall health risks for patients:
The potential risks of particulate exposure include irritation to the skin, eye, and respiratory tract, inflammatory response, headache, asthma, and toxic or carcinogenic effects to organs, such as kidneys and liver.
The potential risks of exposure to chemicals released into the device’s air pathway from the PE-PUR foam include headache; dizziness; irritation in the eyes, nose, respiratory tract, and skin; hypersensitivity; nausea/vomiting; and toxic and carcinogenic effects.
Since the Philips recall of ventilators, BiPAP, and CPAP machines was issued on June 14, 2021, there has been discussion about the Philips recall health risks for patients from possible toxic exposures from the polyester-based polyurethane (PE-PUR) sound abatement foam part. It has been said that the harmful foam problem in defective Philips devices might cause cancers, lung diseases, organ failures, and other medical conditions in patients who used these recalled Philips products in the past.
Returning to the June 2021 FDA Safety Communication about the recalled Philips breathing products:
The FDA is analyzing medical device reports (MDRs) related to the affected devices over the period of 2009-2021 for reports that could be related to this issue.
Of course, we will monitor the medical literature and medical device regulatory realm for more insights about the Philips recall health risks for patients.
List of Recalled Philips Products: CPAP and BiPAP Devices, Ventilators
The June 2021 Philips recall FDA Safety Communication also included a table with a list of recalled Philips products, i.e., Philips “product identification” information.
Further, in this document, “Medical Device recall notification (U.S. only) / field safety notice (International Markets)”, from Philips Respironics, there is also some brand-name information for the various Philips Bi-Level PAP, CPAP, and Mechanical Ventilator devices affected by this June 2021 Philips products recall.
Below, from those sources and for quick reference, we present that Philips “product identification” information limited to only those recalled Philips CPAP devices and Philips BiPAP devices as well as Philips ventilators which are intended for home-use by patients in the US:
CPAP and BiPAP Devices: Continuous Ventilator, Non-life Supporting
DreamStation ST, AVAPS
C-Series ASV, S/T, AVAPS
CPAP and BiPAP Devices: Noncontinuous Ventilator
DreamStation CPAP, Auto CPAP, BiPAP
DreamStation Go CPAP, APAP
Dorma 400 CPAP
Dorma 500 CPAP
REMStar SE Auto CPAP
Ventilators: Continuous Ventilator
Garbin Plus, Aeris, LifeVent
We will watch for any additional, new Philips recall “product identification” information that might be forthcoming from Philips, or the FDA as well as other medical device regulatory agencies around the world. To the extent necessary, we will modify the above list of recalled Philips products.
(Last updated: 7/2/2021)
- Philips Breathing Devices Recall: Legal Cases Overview
- Philips CPAP Machines Recall: FDA Warning Issued in July 2021